{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:50:23Z","timestamp":1778709023945,"version":"3.51.4"},"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T00:00:00Z","timestamp":1580342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0225861","type":"journal-article","created":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T13:40:05Z","timestamp":1580391605000},"page":"e0225861","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Impact of chemorophylaxis policy for AIDS-immunocompromised patients on emergence of bacterial resistance"],"prefix":"10.1371","volume":"15","author":[{"given":"Ashley A.","family":"DeNegre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kellen","family":"Myers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0233-1404","authenticated-orcid":true,"given":"Nina H.","family":"Fefferman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,1,30]]},"reference":[{"issue":"9448","key":"pone.0225861.ref001","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/S0140-6736(04)17442-4","article-title":"Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial","volume":"364","author":"C Chintu","year":"2004","journal-title":"The Lancet"},{"issue":"5","key":"pone.0225861.ref002","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1086\/367655","article-title":"Review of Human Immunodeficiency Virus Type 1-Related Opportunistic Infections in Sub-Saharan Africa","volume":"36","author":"CB Holmes","year":"2003","journal-title":"Clinical Infectious Diseases"},{"issue":"6","key":"pone.0225861.ref003","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3109\/00365549409008630","article-title":"BACTEREMIA IN HIV-POSITIVE AND AIDS PATIENTS\u2014INCIDENCE, SPECIES DISTRIBUTION, RISK-FACTORS, OUTCOME, AND INFLUENCE OF LONG-TERM PROPHYLACTIC ANTIBIOTIC-TREATMENT","volume":"26","author":"CN Meyer","year":"1994","journal-title":"Scand J Infect Dis"},{"issue":"2","key":"pone.0225861.ref004","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2105\/AJPH.90.2.223","article-title":"Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995\u20131997","volume":"90","author":"DR Feikin","year":"2000","journal-title":"Am J Public Health"},{"issue":"9163","key":"pone.0225861.ref005","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/S0140-6736(99)03465-0","article-title":"Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, C\u00f4te d'Ivoire: a randomised controlled trial","volume":"353","author":"SZ Wiktor","year":"1999","journal-title":"The Lancet"},{"issue":"RR-4","key":"pone.0225861.ref006","first-page":"1","article-title":"Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recommendations & Reports","volume":"58","author":"JE Kaplan","year":"2009"},{"issue":"4","key":"pone.0225861.ref007","doi-asserted-by":"crossref","first-page":"e0003748","DOI":"10.1371\/journal.pntd.0003748","article-title":"Rapid Emergence of Multidrug Resistant, H58-Lineage Salmonella Typhi in Blantyre, Malawi","volume":"9","author":"NA Feasey","year":"2015","journal-title":"PLOS Neglected Tropical Diseases"},{"issue":"4","key":"pone.0225861.ref008","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0891-5520(05)70392-5","article-title":"ANTIMICROBIAL RESISTANCE IN STAPHYLOCOCCI: Epidemiology, Molecular Mechanisms, and Clinical Relevance","volume":"11","author":"MC Maranan","year":"1997","journal-title":"Infectious Disease Clinics of North America"},{"issue":"5469","key":"pone.0225861.ref009","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1126\/science.288.5469.1251","article-title":"High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection","volume":"288","author":"A Oliver","year":"2000","journal-title":"Science"},{"issue":"1","key":"pone.0225861.ref010","first-page":"30","article-title":"Antibiotic Resistance, Mutation Rates and MRSA","volume":"1","author":"L. Pray","year":"2008","journal-title":"Nature Education"},{"issue":"8","key":"pone.0225861.ref011","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S1473-3099(05)70189-4","article-title":"Antimicrobial resistance in developing countries. Part I: recent trends and current status","volume":"5","author":"IN Okeke","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"pone.0225861.ref012","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S1473-3099(05)70217-6","article-title":"Antimicrobial resistance in developing countries. Part II: strategies for containment","volume":"5","author":"IN Okeke","year":"2005","journal-title":"The Lancet Infectious Diseases"},{"issue":"3","key":"pone.0225861.ref013","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3201\/EID2003.121157","article-title":"Surveillance for Antimicrobial Drug Resistance in Under-Resourced Countries","volume":"20","author":"G Vernet","year":"2014","journal-title":"Emerging infectious diseases"},{"issue":"12","key":"pone.0225861.ref014","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","article-title":"Antibiotic resistance\u2014the need for global solutions","volume":"13","author":"R Laxminarayan","year":"2013","journal-title":"The Lancet Infectious Diseases"},{"key":"pone.0225861.ref015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/1743-422X-8-401","article-title":"The epidemic of HIV\/AIDS in developing countries; the current scenario","volume":"8","author":"MZ Yousaf","year":"2011","journal-title":"Pakistan. Virol J"},{"issue":"1","key":"pone.0225861.ref016","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1758-2652-14-15","article-title":"Driving a decade of change: HIV\/AIDS, patents and access to medicines for all","volume":"14","author":"Hoen Et","year":"2011","journal-title":"Journal of the International AIDS Society"},{"issue":"10","key":"pone.0225861.ref017","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/QAD.0b013e328354622a","article-title":"The evolving epidemiology of HIV\/AIDS","volume":"26","author":"KM De Cock","year":"2012","journal-title":"Aids"},{"issue":"9534","key":"pone.0225861.ref018","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(06)69158-7","article-title":"The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings","volume":"368","author":"CF Gilks","year":"2006","journal-title":"The Lancet"},{"issue":"4","key":"pone.0225861.ref019","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrmicro2536","article-title":"Shifting the balance: antibiotic effects on host\u2013microbiota mutualism","volume":"9","author":"BP Willing","year":"2011","journal-title":"Nature Reviews Microbiology"},{"issue":"2","key":"pone.0225861.ref020","doi-asserted-by":"crossref","first-page":"e0212969","DOI":"10.1371\/journal.pone.0212969","article-title":"Emergence of antibiotic resistance in immunocompromised host populations: A case study of emerging antibiotic resistant tuberculosis in AIDS patients","volume":"14","author":"AA DeNegre","year":"2019","journal-title":"PLOS ONE"},{"key":"pone.0225861.ref021","unstructured":"CIA. Central Intelligence Agency World Factbook\u2014Indonesia 2013 Available from: https:\/\/www.cia.gov\/library\/publications\/the-world-factbook\/geos\/id.html."},{"key":"pone.0225861.ref022","unstructured":"CIA. Central Intelligence Agency World Factbook\u2014Swaziland 2013. Available from: https:\/\/www.cia.gov\/library\/publications\/the-world-factbook\/geos\/wz.html."},{"key":"pone.0225861.ref023","volume-title":"Global tuberculosis report 2012","author":"World Health Organization","year":"2012"},{"issue":"8","key":"pone.0225861.ref024","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1469-0691.2010.03279.x","article-title":"Point-of-care tests for diagnosing infections in the developing world","volume":"16","author":"RW Peeling","year":"2010","journal-title":"Clinical Microbiology and Infection"},{"issue":"1","key":"pone.0225861.ref025","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1086\/599374","article-title":"World Health Organization Ranking of Antimicrobials According to Their Importance in Human Medicine: A Critical Step for Developing Risk Management Strategies for the Use of Antimicrobials in Food Production Animals","volume":"49","author":"FJ Angulo","year":"2009","journal-title":"Clinical Infectious Diseases"},{"key":"pone.0225861.ref026","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1038\/nm1145","article-title":"Antibacterial resistance worldwide: causes, challenges and responses","volume":"10","author":"SB Levy","year":"2004","journal-title":"Nature Medicine"},{"issue":"25","key":"pone.0225861.ref027","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1161\/01.CIR.101.25.2916","article-title":"Prolonged Antibiotic Prophylaxis After Cardiovascular Surgery and Its Effect on Surgical Site Infections and Antimicrobial Resistance","volume":"101","author":"S Harbarth","year":"2000","journal-title":"Circulation"},{"issue":"4","key":"pone.0225861.ref028","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/jac\/dkl017","article-title":"Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK","volume":"57","author":"CG Gemmell","year":"2006","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"24","key":"pone.0225861.ref029","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJM199606133342404","article-title":"Rifampin-Resistant Tuberculosis in a Patient Receiving Rifabutin Prophylaxis","volume":"334","author":"WR Bishai","year":"1996","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"pone.0225861.ref030","doi-asserted-by":"crossref","first-page":"e77712","DOI":"10.1371\/journal.pone.0077712","article-title":"Rifampicin Mono-Resistance in Mycobacterium tuberculosis in Kwazulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV regi\u00f3n","volume":"8","author":"YM Coovadia","year":"2013","journal-title":"PLoS ONE"},{"issue":"5","key":"pone.0225861.ref031","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF01964427","article-title":"Efficacy of pyrimethamine\/sulfadoxine in the prevention of toxoplasmic encephalitis relapses andPneumocystis carinii pneumonia in HIV-infected patients","volume":"12","author":"B Ruf","year":"1993","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"issue":"1","key":"pone.0225861.ref032","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/infdis\/jit132","article-title":"HIV Treatments Have Malaria Gametocyte Killing and Transmission Blocking Activity","volume":"208","author":"CV Hobbs","year":"2013","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"pone.0225861.ref033","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1086\/517302","article-title":"Evolution of Mutations Conferring Multidrug Resistance during Prophylaxis and Therapy for Cytomegalovirus Disease","volume":"176","author":"S Chou","year":"1997","journal-title":"Journal of Infectious Diseases"},{"issue":"14","key":"pone.0225861.ref034","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.160.14.2101","article-title":"Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence","volume":"160","author":"M DiMatteo","year":"2000","journal-title":"Archives of Internal Medicine"},{"issue":"10","key":"pone.0225861.ref035","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3201\/eid0810.020349","article-title":"Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence","volume":"8","author":"CW Shepard","year":"2002","journal-title":"Emerging Infectious Diseases"},{"issue":"5","key":"pone.0225861.ref036","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to Medication","volume":"353","author":"L Osterberg","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"pone.0225861.ref037","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3201\/eid0501.990103","article-title":"Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries","volume":"5","author":"IN Okeke","year":"1999","journal-title":"Emerging Infectious Diseases"},{"issue":"2","key":"pone.0225861.ref038","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/17290376.2004.9724833","article-title":"Willingness to pay for treatment with highly active antiretroviral (HAART) drugs: a rural case study in Cameroon","volume":"1","author":"KN Muko","year":"2004","journal-title":"SAHARA-J: Journal of Social Aspects of HIV\/AIDS"},{"issue":"4","key":"pone.0225861.ref039","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/heapol\/czq004","article-title":"The financial burden of HIV care, including antiretroviral therapy, on patients in three sites in Indonesia","volume":"25","author":"S Riyarto","year":"2010","journal-title":"Health Policy and Planning"},{"issue":"10","key":"pone.0225861.ref040","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1099\/00221287-145-10-2857","article-title":"Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa","volume":"145","author":"A Alonso","year":"1999","journal-title":"Microbiology"},{"issue":"5","key":"pone.0225861.ref041","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1369-5274(99)00005-3","article-title":"The biological cost of antibiotic resistance","volume":"2","author":"DI Andersson","year":"1999","journal-title":"Curr Opin Microbiol"},{"issue":"22","key":"pone.0225861.ref042","doi-asserted-by":"crossref","first-page":"12106","DOI":"10.1073\/pnas.94.22.12106","article-title":"Evaluating treatment protocols to prevent\u2009antibiotic\u2009resistance","volume":"94","author":"S Bonhoeffer","year":"1997","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"pone.0225861.ref043","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijantimicag.2004.02.015","article-title":"Antimicrobial resistance in developing countries and responsible risk factors","volume":"24","author":"DK Byarugaba","year":"2004","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"7","key":"pone.0225861.ref044","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1128\/AAC.38.7.1447","article-title":"Transfer of antibiotic resistance genes between gram-positive and gram-negative bacteria","volume":"38","author":"P. Courvalin","year":"1994","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"5","key":"pone.0225861.ref045","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0924-8579(01)00317-X","article-title":"Antibiotic selective pressure and development of bacterial resistance","volume":"17","author":"M Kol\u00e1\u0159","year":"2001","journal-title":"International Journal of Antimicrobial Agents"},{"issue":"3","key":"pone.0225861.ref046","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1073\/pnas.96.3.800","article-title":"Disease transmission dynamics and the evolution of antibiotic resistance in hospitals and communal settings","volume":"96","author":"SA Levin","year":"1999","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"pone.0225861.ref047","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jac\/49.1.25","article-title":"Factors impacting on the problem of antibiotic resistance","volume":"49","author":"SB Levy","year":"2002","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"pone.0225861.ref048","first-page":"1","volume-title":"Ciba Foundation Symposium 207\u2014Antibiotic Resistance: Origins, Evolution, Selection and Spread","author":"SB Levy","year":"2007"},{"issue":"3","key":"pone.0225861.ref049","first-page":"32","article-title":"The challenge of antibiotic resistance","volume":"278","author":"SB Levy","year":"1998","journal-title":"Scientific American"},{"issue":"18","key":"pone.0225861.ref050","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1097\/00002030-199818000-00007","article-title":"Immune activation in HIV-infected African individuals","volume":"12","author":"G Rizzardini","year":"1998","journal-title":"AIDS"},{"issue":"1","key":"pone.0225861.ref051","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/1471-2334-11-273","article-title":"The influence of different helminth infection phenotypes on immune responses against HIV in co-infected adults in South Africa","volume":"11","author":"ZL Mkhize-Kwitshana","year":"2011","journal-title":"BMC Infectious Diseases"},{"issue":"9443","key":"pone.0225861.ref052","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(04)17225-5","article-title":"Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda","volume":"364","author":"J Mermin","year":"2004","journal-title":"The Lancet"},{"key":"pone.0225861.ref053","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/01.aids.0000299411.75269.e8","article-title":"Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy","volume":"21","author":"J Todd","year":"2007","journal-title":"AIDS"},{"issue":"9903","key":"pone.0225861.ref054","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(13)61809-7","article-title":"The end of AIDS: HIV infection as a chronic disease","volume":"382","author":"SG Deeks","journal-title":"The Lancet"},{"issue":"5","key":"pone.0225861.ref055","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jac\/dkh438","article-title":"Impact of highly active antiretroviral therapy on incidence and management of human immunodeficiency virus-related opportunistic infections","volume":"54","author":"C-C Hung","year":"2004","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"3","key":"pone.0225861.ref056","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1365-2249.2004.02551.x","article-title":"Correlation of virulence, lung pathology, bacterial load and delayed type hypersensitivity responses after infection with different Mycobacterium tuberculosis genotypes in a BALB\/c mouse model","volume":"137","author":"J Dormans","year":"2004","journal-title":"Clinical & Experimental Immunology"},{"issue":"8","key":"pone.0225861.ref057","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1128\/AAC.43.8.1866","article-title":"Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis","volume":"43","author":"O Billington","year":"1999","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"2","key":"pone.0225861.ref058","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1165\/ajrcmb\/6.2.235","article-title":"Allometric Relationships of Cell Numbers and Size in the Mammalian Lung","volume":"6","author":"KC Stone","year":"1992","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"2","key":"pone.0225861.ref059","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nm.1915","article-title":"A replication clock for Mycobacterium tuberculosis","volume":"15","author":"WP Gill","year":"2009","journal-title":"Nat Med"},{"issue":"1","key":"pone.0225861.ref060","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/A:1007400519792","article-title":"Frequency and determinants of use of antiretroviral and prophylactic therapies against Pneumocystis carinii pneumonia (PCP) before AIDS diagnosis in Italy","volume":"14","author":"PA Napoli","year":"1998","journal-title":"European Journal of Epidemiology"},{"issue":"4","key":"pone.0225861.ref061","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/heapol\/8.4.291","article-title":"Patients' compliance with medical treatments in the third world","volume":"8","author":"N Homedes","year":"1993","journal-title":"What do we know? Health Policy and Planning"},{"issue":"6","key":"pone.0225861.ref062","doi-asserted-by":"crossref","first-page":"e718","DOI":"10.1542\/peds.2004-1133","article-title":"How Do You Improve Compliance?","volume":"115","author":"S Winnick","year":"2005","journal-title":"Pediatrics"},{"issue":"12","key":"pone.0225861.ref063","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1745-7599.2006.00184.x","article-title":"Antibiotic-taking experiences of undergraduate college students","volume":"18","author":"BS Aronson","year":"2006","journal-title":"Journal of the American Academy of Nurse Practitioners"},{"issue":"5","key":"pone.0225861.ref064","doi-asserted-by":"crossref","first-page":"e63273","DOI":"10.1371\/journal.pone.0063273","article-title":"Factors Associated with Coverage of Cotrimoxazole Prophylaxis in HIV-Exposed Children in South Africa","volume":"8","author":"D Moodley","year":"2013","journal-title":"PLoS ONE"},{"issue":"4","key":"pone.0225861.ref065","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0277-9536(02)00422-7","article-title":"Improving antibiotic use in low-income countries: an overview of evidence on determinants","volume":"57","author":"A Radyowijati","year":"2003","journal-title":"Social Science & Medicine"},{"issue":"2","key":"pone.0225861.ref066","doi-asserted-by":"crossref","first-page":"128","DOI":"10.7326\/0003-4819-133-2-200007180-00012","article-title":"Cultural and Economic Factors That (Mis)Shape Antibiotic Use: The Nonpharmacologic Basis of Therapeutics","volume":"133","author":"J Avorn","year":"2000","journal-title":"Annals of Internal Medicine"},{"issue":"2","key":"pone.0225861.ref067","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jinf.2004.12.001","article-title":"Irrational use of antibiotics among university students","volume":"51","author":"C Buke","year":"2005","journal-title":"Journal of Infection"},{"issue":"10","key":"pone.0225861.ref068","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.3390\/ijerph9103519","article-title":"Self-medication practices with antibiotics among tertiary level students in Accra, Ghana: a cross-sectional study","volume":"9","author":"ES Donkor","year":"2012","journal-title":"International journal of environmental research and public health"},{"issue":"2","key":"pone.0225861.ref069","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1420-9101.2008.01658.x","article-title":"Virulence evolution and the trade-off hypothesis: history, current state of affairs and the future","volume":"22","author":"S Alizon","year":"2009","journal-title":"Journal of Evolutionary Biology"},{"key":"pone.0225861.ref070","first-page":"66","volume-title":"Global tuberculosis report 2012","author":"WH Organization","year":"2012"},{"issue":"5721","key":"pone.0225861.ref071","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/280361a0","article-title":"Population biology of infectious diseases: Part I","volume":"280","author":"RM Anderson","year":"1979","journal-title":"Nature"},{"key":"pone.0225861.ref072","volume-title":"The Stop TB strategy: building on and enhancing DOTS to meet the TB-related Millennium Development Goals","author":"Stop TB Partnership, World Health Organization","year":"2006"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0225861","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T13:40:55Z","timestamp":1580391655000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0225861"}},"subtitle":[],"editor":[{"given":"Daniela Flavia","family":"Hozbor","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,30]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0225861","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,30]]}}}